Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, Mesco Pharmaceuticals has informed about submission of certificate received from its Registrar and Transfer Agent (RTA), Skyline Financial Services, confirming the dematerialization of share certificates for the quarter ended 31st March, 2020.
The above information is a part of company's filings submitted to BSE.